RIP(K)ing away immunotherapy resistance
- PMID: 35417670
- DOI: 10.1016/j.immuni.2022.03.010
RIP(K)ing away immunotherapy resistance
Abstract
Interferon signaling mediates resistance to immune checkpoint blockade therapy, but the underlying mechanisms are poorly understood. In this issue of Immunity, Cucolo et al. identify RIPK1 as an interferon-stimulated gene with potent effects on cell extrinsic and intrinsic immunotherapy resistance.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests S.F.T. is a co-founder, shareholder, and member of the scientific advisory board of Inspirna.
Comment on
-
The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade.Immunity. 2022 Apr 12;55(4):671-685.e10. doi: 10.1016/j.immuni.2022.03.007. Immunity. 2022. PMID: 35417675 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
